Objective Access to vital raw ingredients for food/feed production is an increasing challenge in several industries. Biopharmia is a Norwegian company focusing on cultivation of microalgae through its development of a proprietary bioreactor. Through years of expertise and collaborations with experts in the field of microalgae growth, Biopharmia have developed and patented the Accordion bioreactor, a proven and efficient platform for industrial scale production of high quality microalgae, at lower energy and decreased production cost, compared to other solutions. This technology aims to strengthen Europe’s position in the microalgae market, which is currently weak due to cheaper, low quality foreign competitors. The technology describes the unique wave configuration comprising the frame work of the bioreactor, which contributes to higher productivity and lower cost of production and investment when compared to competing technologies. The modular design of this closed system greatly minimises the risk of contamination and can be easily adapted to large scale production. Biopharmia need to undertake the proposed innovation project to develop and further test the Accordion technology with multiple algae strains. The company has a close collaboration with the University of Arizona (UA) and has demonstrated the efficiency and productivity of its bioreactors through extensive testing at UA. Biopharmia has supplied biomass to a number of entities in Norway with very good results. Biopharmia has Letters of Intent about supply of biomass to two Norwegian customers in different segments, food supplements and aquaculture. In 2012 the company raised €1 million in private venture capital from IFE Venture. Biopharmia intends to establish initial production using the Accordion technology for the clients the company have an LOI with before expanding production. Fields of science agricultural sciencesagriculture, forestry, and fisheriesfisheriesengineering and technologyenvironmental biotechnologybioremediationbioreactorssocial scienceseconomics and businesseconomicsproduction economicsproductivitysocial scienceseconomics and businesseconomicssustainable economyagricultural sciencesagricultural biotechnologybiomass Programme(s) H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy Main Programme H2020-EU.3.2.5. - Cross-cutting marine and maritime research H2020-EU.3.2.3. - Unlocking the potential of aquatic living resources H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Topic(s) SMEInst-08-2016-2017 - Supporting SMEs efforts for the development - deployment and market replication of innovative solutions for blue growth Call for proposal H2020-SMEInst-2016-2017 See other projects for this call Sub call H2020-SMEINST-1-2016-2017 Funding Scheme SME-1 - SME instrument phase 1 Coordinator BIOPHARMIA AS Net EU contribution € 50 000,00 Address PO Box 34 Kjelsås 0411 OSLO Norway See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Norge Oslo og Viken Oslo Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 71 429,00